Haemonetics | HAE - 销售成本



金融业
股票价格
USD
资产
USD 2.37B
现金及等价物
USD 223.38M
销售成本
USD 136.58M
流动资产
USD 810.83M
流动负债
USD 263.24M
债务
USD 1.22B
EBIT
USD 57.46M
EBITDA
USD 96.17M
员工
3.02K
EPS每股收益
USD 1.14
股本和储备
USD 837.1M
销售毛利
USD 202.8M
债务利息支出
USD 5.08M
利息收入
USD 6.96M
贷款资金
USD 1.17B
市值
USD 5.47B
净收入
USD 33.01M
营业费用
USD 145.35M
营业利润
USD 57.46M
普通股股本
USD 45.47M
PE价格收益
17.35
税前利润
USD 47.57M
销售收入
USD 339M
销售和管理费用
USD 118.94M
股票
USD 306.74M
贸易债权人
USD 56.34M
应收帐款人
USD 216.07M


销售成本 更改 日
Baxter International USD 1.93B 118M 2026-06
Becton, Dickinson and Co. USD 2.67B 108M 2026-06
Boston Scientific USD 1.86B 29M 2026-06
Cerus USD 23.42M 3.61M 2024-12
Cooper Companies USD 393.8M 17M 2026-03
Fresenius EUR 4.4B 111M 2026-06
Fresenius Medical Care EUR 3.55B 117.58M 2026-06
Globus Medical USD 271M 7.41M 2026-06
Haemonetics USD 136.58M 11.56M 2026-06
ICU Medical USD 316.63M 7.37M 2026-06
Intuitive Surgical USD 931.9M 8.4M 2026-06
Medtronic USD 3.8B 195M 2026-03
Merit Medical Systems USD 203.68M 6.6M 2026-06
Neogen USD 117.5M 5.3M 2026-03
OraSure Technologies USD 15.43M 113K 2025-12
Quidel USD 407M 486.5M 2026-06
ResMed USD 612.93M 61.26M 2026-06
STAAR Surgical USD 23.81M 855K 2026-06
Steris USD 808.6M 82.7M 2026-06
Stryker USD 2.26B 106M 2026-06
Teleflex USD 238.62M 2.21M 2026-06
Terumo JPY 133.27B 18.03B 2026-06
Thermo Fisher Scientific USD 7.54B 577M 2026-06
US Physical Therapy USD 169.99M 6.39M 2026-06
Zimmer Biomet Holdings USD 815.9M 77.6M 2026-06